Munich, Germany – October 18, 2004 – Bicoll GmbH, Munich announced today that it has generated an
after-tax profit in the last fiscal year, in its third year of operation. Bicoll is specialized in high-tech
natural product chemistry with a focus to make compounds from natural resources compatible with
drug discovery systems in modern drug research.
Bicoll’s primary products are optimized small molecule libraries for drug discovery in the biopharmaceutical industry. The libraries are tested and developed for fee and milestone payments in
co-operations. They are customized to the target protein of the partner’s indication field to provide
a high success rate in screening and further development. The starting material is generated from
endemic Asian plant resources.